The structural basis of phenylketonuria

被引:125
作者
Erlandsen, H
Stevens, RC [1 ]
机构
[1] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA
关键词
phenylalanine hydroxylase; hyperphenylalaninemia; phenylketonuria; structure-function relationship;
D O I
10.1006/mgme.1999.2922
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The human phenylalanine hydroxylase gene (PAR) (locus on human chromosome 12q24.1) contains the expressed nucleotide sequence which encodes the hepatic enzyme phenylalanine hydroxylase (PheOH). The PheOH enzyme hydroxylates the essential amino acid L-phenylalanine resulting in another amino acid, tyrosine. This is the major pathway for catabolizing dietary L-phenylalanine and accounts for approximately 75% of the disposal of this amino acid. The autosomal recessive disease phenylketonuria (PKU) is the result of a deficiency of PheOH enzymatic activity due to mutations in the PAR gene. Of the mutant alleles that cause hyperphenylalaninemia or PKU 99% map to the PAR gene. The remaining 1% maps to several genes that encode enzymes involved in the biosynthesis or regeneration of the cofactor ((6R)-L-erythro-5,6,7,8-tetrahydrobiopterin) regenerating the cofactor (tetrahydrobiopterin) necessary for the hydroxylation reaction. The recently solved crystal structures of human phenylalanine hydroxylase provide a structural scaffold for explaining the effects of some of the mutations in the PAR gene and suggest future biochemical studies that may increase our understanding of the PKU mutations. (C) 1999 Academic Press.
引用
收藏
页码:103 / 125
页数:23
相关论文
共 93 条
[21]  
Eisensmith Randy C., 1992, Human Mutation, V1, P13, DOI 10.1002/humu.1380010104
[22]  
EISENSMITH RC, 1995, AM J HUM GENET, V57, P926
[23]   Crystal structure of the catalytic domain of human phenylalanine hydroxylase reveals the structural basis for phenylketonuria [J].
Erlandsen, H ;
Fusetti, F ;
Martinez, A ;
Hough, E ;
Flatmark, T ;
Stevens, RC .
NATURE STRUCTURAL BIOLOGY, 1997, 4 (12) :995-1000
[24]  
Flatmark T, 1997, CHEMISTRY AND BIOLOGY OF PTERIDINES AND FOLATES 1997, P503
[25]  
FORREST SM, 1991, AM J HUM GENET, V49, P175
[26]   Structure of tetrameric human phenylalanine hydroxylase and its implications for phenylketonuria [J].
Fusetti, F ;
Erlandsen, H ;
Flatmark, T ;
Stevens, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (27) :16962-16967
[27]   IDENTIFICATION OF A NEW MISSENSE MUTATION IN JAPANESE PHENYLKETONURIC PATIENTS [J].
GOEBELSCHREINER, B ;
SCHREINER, R .
JOURNAL OF INHERITED METABOLIC DISEASE, 1993, 16 (06) :950-956
[28]  
GOLTSOV A, 1994, AM J HUM GENET, V55, P1288
[29]   Crystal structure of tyrosine hydroxylase with bound cofactor analogue and iron at 2.3 Å resolution:: Self-hydroxylation of Phe300 and the pterin-binding site [J].
Goodwill, KE ;
Sabatier, C ;
Stevens, RC .
BIOCHEMISTRY, 1998, 37 (39) :13437-13445
[30]   MOLECULAR ANALYSIS OF PHENYLKETONURIA IN DENMARK - 99-PERCENT OF THE MUTATIONS DETECTED BY DENATURING GRADIENT GEL-ELECTROPHORESIS [J].
GULDBERG, P ;
HENRIKSEN, KF ;
GUTTLER, F .
GENOMICS, 1993, 17 (01) :141-146